Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes
Shannon R. McCurdy(Hospital of the University of Pennsylvania), Ephraim J. Fuchs(Johns Hopkins University), Heather J. Symons(Johns Hopkins University), Maria P. Bettinot(Johns Hopkins University), Leo Luznik(Johns Hopkins University), Stephen Muth(Johns Hopkins University), William Matsui(The University of Texas at Austin), Ivan Borrello(Tampa General Hospital), Richard J. Jones(Sidney Kimmel Comprehensive Cancer Center), Kenneth R. Cooke(Johns Hopkins University), Richard F. Ambinder(Johns Hopkins University), Ravi Varadhan(Johns Hopkins University), Robert A. Brodsky(Johns Hopkins University), Carol Ann Huff(Sidney Kimmel Comprehensive Cancer Center), Hua-Ling Tsai(Johns Hopkins University), Douglas E. Gladstone(Northwell Health), Lode J. Swinnen(Johns Hopkins University), Javier Bolaños‐Meade(Johns Hopkins University)
Cited by 41
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Frailty in Older Adults: A Nationally Representative Profile in the United States
|The Journals of Gerontology Series A|2015|789